AGNC Investment Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between May 23, 2018, and May 29, 2018. AGNC Investment Corp. (the "Company") entered into a material definitive agreement to raise capital through a public offering of common stock.
Key Financial Metrics and Transaction Details
The filing details a primary equity offering rather than operational financial results. Key transaction metrics include:
- Primary Offering: Sale of 30,000,000 shares of common stock.
- Over-Allotment Option: Grant of an option to purchase up to 4,500,000 additional shares.
- Closing Date: The sale of shares, including the full exercise of the option, closed on May 29, 2018.
- Underwriters: Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, and UBS Securities LLC.
The filing text does not provide the offering price per share, total gross proceeds, or specific net proceeds after underwriting discounts. Consequently, specific impacts on revenue, profit, cash flow, margins, debt, or liquidity cannot be quantified from this document alone.
Material Changes
The primary material change is the increase in the Company's outstanding share count due to the issuance of 30,000,000 shares plus the full exercise of the 4,500,000 share option. This transaction represents a significant capital raise intended to fund the Company's operations and investment activities.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond standard underwriting agreement terms. The Underwriting Agreement includes customary representations, warranties, covenants, and indemnification provisions for losses arising from the sale of the shares. The underwriters and their affiliates may engage in various banking and advisory services with the Company for which they receive customary fees.
Investor Verification Checklist
- Verify the offering price per share and total gross proceeds in the associated Prospectus Supplement (File No. 333-205306).
- Confirm the exact number of shares issued upon the full exercise of the 4,500,000 share option.
- Review the Company's subsequent 10-Q or 10-K filings to assess the impact of this capital raise on liquidity, leverage ratios, and earnings per share.
- Check for any dilution effects on existing shareholders resulting from the issuance of 34,500,000 total shares.